Year: 2023
Type: dissertation
Abstract: Hippo pathway is a signaling pathway that plays an important role in cell proliferation and cancer metastasis. Several diseases such as cancer are related to the improper regulation of this pathway. Overactivation of YAP and TAZ proteins, the main effectors of Hippo pathway, accelerates cell proliferation, migration, and invasion during tumorigenesis. Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug (NSAID) that exhibits anti-cancer activity against various types of cancer. In this study, it was observed that TA decreased YAP and TAZ protein level in cancer cells. TA increased the YAP and TAZ phosphorylation, leading to YAP/TAZ degradation in the cytoplasm and nucleus. TA predominantly affected phosphodegron sites in TAZ, causing TAZ to enter the ubiquitination pathway. Proteins that affect YAP/TAZ protein level, such as NAG-1 and several YAP/TAZ E3 ligases, were not involved in TA-mediated YAP/TAZ degradation. In summary, our results indicate that TA affects phosphodegron sites on TAZ, which demonstrates a novel effect of TA in tumorigenesis.
Author: 김일주
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7015630448
